Quick Answer
VitaNova Life Sciences Corp reported Stockholders Equity of $1.91 million for fiscal year 2025.
VitaNova Life Sciences Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.91M | +80.8% |
| 2024 | $1.06M | +1883.2% |
| 2023 | -$59.2K | -69.2% |
| 2022 | -$35.0K | +80.0% |
| 2021 | -$174.7K | -42.5% |
| 2020 | -$122.6K | -144.0% |
| 2019 | -$50.2K | -219.2% |
| 2018 | $42.2K | +1247.1% |
| 2017 | -$3.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $1.85M | +67.3% | -2.3% |
| October 31, 2025 | $1.90M | +83.4% | +1.9% |
| July 31, 2025 | $1.86M | +86.0% | -2.4% |
| April 30, 2025 | $1.91M | +80.8% | +72.2% |
| January 31, 2025 | $1.11M | +27.3% | +7.1% |
| October 31, 2024 | $1.03M | +1222.2% | +3.3% |
| July 31, 2024 | $1.00M | +1299.9% | -5.2% |
| April 30, 2024 | $1.06M | +1883.2% | +21.3% |
- VitaNova Life Sciences Corp showed an increase of +80.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, VitaNova Life Sciences Corp’s stockholders equity has grown by 52037.0% (from -$3.7 thousand to $1.91 million).
- The most recent figure is from VitaNova Life Sciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: